1. Eton EA, Zhao PY, Johnson MW, et al. Rhegmatogenous Retinal Detachment Following Initiation of Pilocarpine Hydrochloride Ophthalmic Solution 1.25% for Treatment of Presbyopia. Retin Cases Brief Rep 2022.
2. Zhao PY, Branham K, Schlegel D, et al. Automated Segmentation of Autofluorescence Lesions in Stargardt Disease. Ophthalmol Retina 2022:S2468-6530(22)00265–2.
3. Deng C, Zhao PY, Branham K, et al. Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis. Graefes Arch Clin Exp Ophthalmol 2022;260:1543–1550.
4. Zhao PY, Johnson MW, McDonald HR, Sarraf D. Paracentral Acute Middle Maculopathy and the Ischemic Cascade: Toward Interventional Management. Am J Ophthalmol 2022;234:15–19.
5. Zhao PY, Ji S, Newman-Casey PA, et al. Assessing patient perception of risk in ocular stem cell therapies. Stem Cell Reports 2021;16:2415–2421.
6. Zhao PY, Branham K, Schlegel D, et al. Association of No-Cost Genetic Testing Program Implementation and Patient Characteristics With Access to Genetic Testing for Inherited Retinal Degenerations. JAMA Ophthalmol 2021;139:449–455.
7. Lindeke-Myers A, Zhao PY, Meyer BI, et al. Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care. JAMA Ophthalmol 2021;139:508–515.
8. Zhao PY, Hovland PG, Fahim AT. Cystoid macular edema precipitated by altitude in a patient with X-linked retinitis pigmentosa. Ophthalmic Genet 2020;41:275–278.
9. Zhao PY, Abalem MF, Nadelman D, et al. Peripheral Pigmented Retinal Lesions in Stargardt Disease. Am J Ophthalmol 2018;188:104–110.